Weisi Medical (688580.SH) to Invest RMB 70 Million in Funds Targeting Healthcare and Life Sciences

Yicai Global APP reported that VISHEE (688580.SH) announced the company plans to subscribe as a limited partner to 50 million yuan of Changzhou Jifeng Equity Investment Partnership (Limited Partnership) ("Jifeng IV Fund") and 20 million yuan of Suzhou Minyun Yaosheng Venture Capital Partnership (Limited Partnership) ("Minyun II Fund"). It is reported that Jifeng IV Fund mainly invests in enterprises in the fields of healthcare and life sciences, while Minyun II Fund focuses on early-stage and growth-stage next-generation medical device companies.